North J H, Pack M S, Hong C, Rivera D E
Department of Surgery, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905, USA.
Am Surg. 1998 May;64(5):437-40.
Carcinoma of the gallbladder is a rare neoplasm and is associated with a dismal prognosis. To analyze the natural history of this disease and prognostic factors, a large tumor registry database was accessed. During the period 1972 to 1995, 214 patients were entered. Adequate follow-up was available on 162 patients, and this group forms the basis of this review. There were 54 males and 108 females with a median age of 62 years. Median follow-up was 7 months. Right upper quadrant abdominal pain was the most frequent presenting symptom. Fifteen patients had an incidental finding of carcinoma after cholecystectomy. Overall, 5-year survival was 25 per cent, with a median survival time of 9.7 months. Survival was improved for patients with local disease compared with those with regional or metastatic disease. One hundred nine patients underwent surgical therapy. Complete resection was possible in 36 patients, whereas 44 patients had residual disease. Median survival time for patients with no residual disease was 67.2 months, whereas those for patients with microscopic residual tumor and gross residual tumor were 8.9 and 3.8 months, respectively (P < 0.000001). Gallbladder cancer is often diagnosed at an advanced stage and is associated with a poor prognosis. In patients with localized disease, surgical treatment provides the opportunity for long-term survival only when a complete resection can be performed. Prognosis for patients with microscopic residual and gross residual disease is similar.
胆囊癌是一种罕见的肿瘤,预后很差。为分析该疾病的自然病程及预后因素,我们检索了一个大型肿瘤登记数据库。在1972年至1995年期间,纳入了214例患者。162例患者有足够的随访资料,该组患者构成了本综述的基础。其中男性54例,女性108例,中位年龄62岁。中位随访时间为7个月。右上腹疼痛是最常见的首发症状。15例患者在胆囊切除术后偶然发现癌。总体而言,5年生存率为25%,中位生存时间为9.7个月。与有区域或转移病灶的患者相比,局限性疾病患者的生存率有所提高。109例患者接受了手术治疗。36例患者可行根治性切除,而44例患者有残留病灶。无残留病灶患者的中位生存时间为67.2个月,而有微小残留肿瘤和肉眼残留肿瘤患者的中位生存时间分别为8.9个月和3.8个月(P<0.000001)。胆囊癌常被诊断为晚期,预后较差。对于局限性疾病患者,只有在能够进行根治性切除时,手术治疗才提供长期生存的机会。有微小残留和肉眼残留疾病患者的预后相似。